Archive for the ‘Drug Side Effects / Complications’ Category

NOW EVALUATING LIPITOR® DIABETES POTENTIAL CLAIMS

June 2013

Statin Medications Such As Lipitor® Linked To Higher Diabetes Risk Especially In Women

If you are a woman who took Lipitor and then developed diabetes you may be entitled to potential compensation.  If after taking Lipitor, or the generic version atorvastatin, you developed diabetes, you may be able to file a lawsuit.

In 2012, clinical trial results caused the United States FDA to update the label of the cholesterol drug Lipitor to reflect an increased risk of type-2 diabetes.

Statins are a class of drugs that lowers cholesterol levels in the blood by reducing the amount of cholesterol the liver produces.

Recent news reports have now announced evidence that millions of people, especially women, taking statin medications to lower their cholesterol may be at a higher risk of developing diabetes.

Patients are advised to continue taking their medications as advised by their physicians.  Each patient should discuss their particular risk / benefit analysis carefully with his or her licensed physician.

The new information about statins and increased diabetes risks may influence the decisions of some doctors and patients about taking the medications.

Individuals taking statins may also want to have their doctors monitor them for signs of diabetes.  Also, those taking statins should be aware of some of the signs of diabetes such as increased thirst and urination, and fatigue.

The use of statins among people older than 45 has increased ten times in the past two decades.  According to the National Center for Health Statistics, 2% of the population over 45 took the medications in the years 1988 – 1994, and 25% between 2005 – 2008.

The FDA announced changes in early 2012 to the safety information on labels of statins such as Pfizer Inc.’s Lipitor.  The drugs are taken by tens of millions of people.

Health regulators are therefore adding warnings to such widely used drugs as Lipitor, stating that the drugs may raise levels of blood sugar, thus increasing diabetes risk.

Lipitor, a drug that became available in 2011 as the generic atorvastatin, is the world’s biggest selling prescription medication of all time, with cumulative sales exceeding $130 billion.

We are currently evaluating potential claims that Lipitor lead to the development of diabetes in some women.

If you or a loved one have been diagnosed with diabetes while taking Lipitor, or its generic version called atorvastatin, we would like to hear from you and mail you some free information on Lipitor and diabetes.

Trademark Notice:

Lipitor® is a registered trademark of Pfizer, Inc.  The use of this name or trademark on this website is only for product identification and information purposes.  Pfizer, Inc. is not affiliated with this website or law firm.  Nothing on this website has been authorized or approved by Pfizer, Inc. or their affiliates.

Who We Are

We are The Mulligan Law Firm, a national law firm located in Dallas, Texas, providing legal information and resources for injured individuals and their families. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995. The Mulligan Law Firm has the strength and experience to represent plaintiffs in all 50 states.

The Mulligan Law Firm is currently investigating injury claims involving Lipitor®.

If you or a loved one has been seriously injured after using Lipitor® it is important that you consult with a legal professional immediately.  The Mulligan Firm’s experienced lawyers are standing by to help you.

You may be entitled to compensation for your injuries. We take all cases on a contingency-fee basis, which means you do not pay for our services unless you receive an award or compensation. Do not delay, as your rights and compensation may be lost forever if you wait.

NOW EVALUATING POTENTIAL PRADAXA® CLAIMS INVOLVING INTERNAL BLEEDING

May 2013

Pradaxa Side Effects Lawyers – Attorneys

Pradaxa Side Effects Lawyers – Attorneys

Did you or a loved one experience side effects or injury from Pradaxa® (Dabigatran)?

Pradaxa®, also known as Dabigatran, is an oral anticoagulant approved by the FDA in 2010.

Pradaxa® is manufactured by Boehringer Ingelheim, a German pharmaceutical company. Pradaxa® is part of the class of medications known as direct thrombin inhibitors and is sold as an alternative to the drug known as Warfarin.

Pradaxa® is primarily used to help prevent strokes and severe or serious blood clots in patients with atrial fibrillation. Atrial fibrillation is a condition where the heart beats irregularly.

Pradaxa® is meant for patients who do not suffer from heart valve disease. In fact, the makers of Pradaxa® advise patients not to use the drug who have had or plan to have a valve in their heart replaced. Consumers should read the medication insert materials carefully for more detailed warnings and contraindications.

Pradaxa® is a blood thinner that is intended to help prevent blood clots from forming in the body. Patients with atrial fibrillation take Pradaxa® because they are at an increased risk of forming blood clots that can lead to strokes and even death.

We are now evaluating potential claims where Pradaxa® has caused dangerous internal bleeding. If you or a loved one have taken Pradaxa® and suffered internal bleeding that has lead to medical care, we would like to speak with you.

Sadly, some patients have even died from bleeding events that potentially are linked to Pradaxa® use.

If you or someone you love has been injured after taking Pradaxa®, please contact a Pradaxa® attorney – lawyer by calling us or filling out any of the forms on this website today.

Please call us today or fill out a form on this website.

PRADAXA® is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG.

Now Evaluating Potential Mirena Claims

March 2013

Mirena IUD Side Effects, Injuries, Revision Surgeries

The Mulligan Law Firm is reviewing potential Mirena lawsuits involving those who were implanted with the intrauterine contraceptive device with the brand name “Mirena®”.

Mirena is a small, t-shaped plastic intrauterine device (IUD) that releases a hormone into the uterus to stop pregnancy. The device is manufactured by Bayer Healthcare Pharmaceuticals.

FDA approved Mirena in 2000 as a contraceptive for women who have had at least one child. In addition, in 2009, the FDA approved Mirena to treat heavy menstrual bleeding.

While marketing Mirena, the FDA warned Bayer that their advertising omitted serious and frequent risks associated with the device.

If you or a loved one have had problems with a MIRENA IUD, including, but not limited to the following, we would like to hear from you:

  • Surgery to remove the IUD
  • Perforation of the Uterus / Uterine Wall
  • Migration or movement of the IUD to location outside of the Uterus
  • Expulsion of the Mirena IUD from the body
  • Infertility
  • Pelvic Inflammatory Disease diagnosis
  • Perforation of the Intestine or other organs
  • Abscess of the Uterus
  • Complications that have resulted in surgery to remove the IUD
  • Infection in the Uterus caused by the Mirena IUD
  • Abscesses
  • Birth of a child with a birth defect
  • Embedment in the uterus
  • Peritonitis or inflammation of the membrane that lines the abdominal cavity and internal organs
  • Other Serious Injuries caused by the Mirena IUD, including sterilization, surgical removal of the uterus, etc.
  • Breast or other types of cancer.
  • Thrombosis – blood clots
  • Ectopic Pregnancy

Over 45,000 adverse events from Mirena have been reported in the United States since Mirena’s introduction.

If you or a loved one have been injured by a Mirena IUD, please contact us as soon as possible. Do not delay as otherwise your statute of limitations period may expire.

Trademark Notice:

Mirena® is a registered trademark of Bayer Healthcare Pharmaceuticals. The use of this name or trademark on this website is only for product identification and information purposes. Bayer Healthcare Pharmaceuticals is not affiliated with this website or law firm. Nothing on this website has been authorized or approved by Bayer Healthcare Pharmaceuticals or their affiliates.

PANEL RECOMMENDS CHANGES TO YAZ, YASMIN, LABELS

December 2011

Advisers to the Food and Drug Administration met on December 8, 2011 to review the science behind Yaz and its class of birth control pills and voted that the drugs’ prescribing label should be changed to better reflect the blood clot risks to women who take the medications.

The advisers voted 21-5 that the information labels for the class of pills should be changed to more clearly reflect the potential for blood clots as a side effect of the medications.

The FDA does not have to follow the panels’ advice.

The clarity of the language and the way the label communicates the information formed part of the discussion about how the label should be updated to warn women who take the class of birth control medications.

Drospirenone is similar to the naturally occurring female hormone progesterone.

The FDA acknowledges that the newest generation birth control pills may raise the risks of blood clots.

Yas and Yasmin and similar medications combine drospirenone, a synthetic versions of the female hormone progesterone, with estradiol, a form of the female hormone estrogen.

Bayer faces thousands of lawsuits over injuries allegedly caused by the medications.

Lawyers have cited FDA reports on at least fifty deaths of those taking the medications between 2004 and 2008.

Some womens’ health advocates are so concerned by Yaz and Yasmin that they believe the medications should be taken off the market since there are safer options available.

Potential Zoloft® And Other SSRI Birth Defects Now Under Evaluation

October 2011

We are actively evaluating omphalocele lawsuits / cases potentially originating from  all 50 states.

If you or somebody you know took an antidepressant while pregnant and your child was born with an omphalocele, you should contact our lawyers immediately.

We are actively seeking birth defects claims like these in order to represent the legal interests of children and families affected by the manufacturer’s failure to warn mothers of the potential for congenital birth defects as a result of taking their products.

What is Omphalocele?

An omphalocele is a congenital hernia in which the infant’s intestine and/or other abdominal organs protrude out of the navel.

Omphaloceles occur when the abdominal wall does not close properly during fetal development.

The extent and seriousness to which abdominal organs protrude through the base of the umbilical cord will vary with each individual case.

What SSRI Antidepressants Are Possibly Linked to Omphalocele?

The following antidepressants are the primary drugs potentially linked to the development of omphalocele in newborn infants and babies if their mothers took these drugs during pregnancy:

•Zoloft (Sertraline)
•Paxil (Paroxetine)
•Lexapro (Escitalopram)
•Celexa (Citalopram)
•Prozac (Fluoxetine)
•Symbyax (fluoxetine and olanzapine)
•Wellbutrin (Bupropion)
•Effexor (Venlafaxine)
•Generics and other types of this class of drugs (SSRI).

If you or a loved one have suffered an injury after taking any of these or other similar drugs, or their generics, please contact us immediately for a free potential claim evaluation.  Failure to act quickly may cause you to lose your potential legal rights if the statute of limitations period passes.

Please fill out any of the contact forms on this website or call us today so that we can mail you a free questionnaire.

If You Or A Loved One Have These Specific Diagnoses From Denture Cream Use – Contact Us Immediately

February 2010

We would like to speak with you immediately if you have any of the following diagnoses from denture cream use:

•  Neuropathy
•  Zinc Poisoning
•  Hypocupremia and/or 
•  Hyperzincemia

Denture Cream Injuries – Zinc Poisoning

February 2010

Various brands of denture creams help to adhere dentures to an individual’s gums and help stop pain and discomfort while wearing dentures. Zinc is found in some denture creams and can be harmful when individuals are exposed to toxic levels.

Fixodent® and Super Poligrip® are two denture creams that contain zinc.

Excessive zinc exposire can lead to several significant health problems.

Research has found that users of denture creams such as Fixodent® and Super Poligrip® are at risk for zinc poisoning.

Zinc Poisoning symptoms include:

- paralysis
- weakness in the extremities
- lack of coordination and/or poor balance
- pain in the extremities
- tingling or numbness
- difficulty urinating
- loss of sensation

Excess levels of Zinc in the blood can also result in the following diagnoses:

- ZINC POISONING
- MYELOPATHY (SPINAL CORD DAMAGE)
- COPPER DEFICIENCY – HYPOCUPREMIA
- NEUROPATHY
- ANEMIA
AND/OR
- BONE MARROW FAILURE

If you or a loved one have used denture creams of any kind and suffer from these or other significant symptoms / injuries, you may be entitled to compensation. Contact The Mulligan Law Firm immediately via this website or 1-866-529-0001, Ext. 245.  Se Habla Espanol

Link between Lantus® and cancer possible

October 2009

Insulin glargine is biosynthetic insulin that imitates NPH human insulin and is prescribed in the treatment of diabetes. This is marketed under the brand name Lantus® by Sanofi-Aventis. Administered through injection, Lantus provides a regulated release which translates into a glucose-lowering effect spread over 24-hours.

Side Effects of Lantus®

The usage of Lantus® has been associated with a greater risk of developing cancer and this has been substantiated through studies. On June 26,2009, Diabetologia, an online journal on diabetes published some new research based on studies conducted on patients drawn from Scotland, Sweden, UK and Germany. A look at the German study revealed that the research on approximately 127,000 patients who used Lantus® showed a link between its usage and a greater risk of developing cancer.

The Diabetologia press release stated that, “Compared with people using similar doses of human insulin, out of every 100 people who used Lantus® insulin over an average of about one-and-a-half years, one additional person was diagnosed with cancer.”

Lantus® & FDA

Lantus® was the first FDA approved long-acting (basal) recombinant human insulin analog.   Based on recent studies, the FDA MedWatch Safety Alert acknowledges that those on Lantus® could be facing an increased risk of developing cancer.

The Law & Lantus®

If you or your loved one has been using Lantus® and developed cancer, you could be potentially entitled to compensation. Contact Eric W. Gruenwald, Attorney / Lawyer for more information at 866-529-0001 Extension 245. Never discontinue any medication without the consent of your physician.

The Acne Drug Accutane® has been Potentially Linked to Inflammatory Bowel Disease, Crohn’s Disease, and Ulcerative Colitis

September 2009

Along with other side-effects, Accutane® is suspected as a possible cause of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Even after treatment with Accutane has been discontinued, these serious digestive disorders can persist.

If someone has taken the acne medication Accutane and is now diagnosed with Crohn’s disease or Ulcerative colitis, they may be entitled to compensation. Contact the Mulligan Law Firm at www.mulliganlaw.com

Dallas, TX September 30, 2009 — Accutane (also known as Isotretinoin) has been used by about 13 million people since it first became available in 1982. Its primary use is for the treatment of severe nodular acne, in patients who fail to respond to other acne treatments such as antibiotics.

Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself. It was Roche’s second-biggest selling drug until the patent expired in 2003, at which time generic versions could be sold.

Potential Side Effects of Accutane: Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD) is defined as a group of inflammatory conditions of the colon and small intestine. The main forms of IBD are Crohn’s disease and ulcerative colitis. While the diseases have features in common, there are important differences.

Ulcerative colitis causes inflammation and sores (ulcers) in the lining of the rectum and colon. The sores form when inflammation has killed the cells that line the colon, which then bleed and produce pus. The main symptom of the disease is recurrent diarrhea mixed with blood. Mucus may also appear in the stool if the lining of the colon is damaged.

Crohn’s disease causes deeper inflammation than Ulcerative Colitis. It can potentially affect other parts of the digestive system, including the small intestine, anus, esophagus, mouth and stomach.

While Crohn’s disease has no known cure, ulcerative colitis can often be cured by surgery, but surgical removal of the large intestine and/or colon are as permanent and life-changing as the disease itself

About The Mulligan Law Firm
The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately, and the Mulligan Firm has experienced lawyers ready to help. Contact Eric Gruenwald, Lawyer/Attorney or Attorney/Lawyer at 866-529-0001, EXT 245.

All cases are taken on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

The Mulligan Law Firm is Investigating Injury Claims: Acne Drug Accutane® has been linked to Inflammatory Bowel Disease, and Other Serious Side-Effects

September 2009

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis.

Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Law Firm has experienced lawyers standing by to help them.

Dallas, TX September 30, 2009 — The Mulligan Law Firm is a national law firm located in Dallas, Texas, providing information and resources for injured individuals and their families in all 50 states. The firm has successfully resolved over $600,000,000 in claims for its clients since 1995.

The Mulligan Law Firm is currently investigating injury claims involving Accutane’s possible role in inflammatory bowel disease, including Crohn’s Disease and ulcerative colitis. Someone who has been seriously injured after taking Accutane should consult with a legal professional immediately. The Mulligan Firm has experienced lawyers standing by to help them. Contact Eric Gruenwald, Lawyer/Attorney or Attorney/Lawyer at 866-529-0001, EXT 245.

Along with other side-effects, Accutane® is suspected as a possible cause of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Even after treatment with Accutane has been discontinued, these serious digestive disorders can persist. While Crohn’s disease has no known cure, ulcerative colitis can often be cured by surgery, but surgical removal of the large intestine and/or colon are as permanent and life-changing as the disease itself.

In the United States, several jury trials have awarded at least $33 million dollars to patients as compensation for injuries attributed to Accutane use. The total number of claims against Roche Holding Ltd., the maker of Accutane, is believed to exceed 5,000, with at least 425 injury cases pending.

After the outcome of these jury trials, Roche Pharmaceuticals notified the FDA that they were immediately discontinuing the distribution and manufacture of Accutane in the United States. One of the reasons given by Roche for the decision: the high cost of personal-injury lawsuits.

The Mulligan Law Firm takes all cases on a contingency-fee basis, which means the prospective client does not pay for our services unless an award or compensation is received.

About Accutane
Accutane (also known as Isotretinoin) has been used by about 13 million people since it first became available in 1982. Its primary use is for the treatment of severe nodular acne, in patients who fail to respond to other acne treatments such as antibiotics.

Accutane works by reducing the amount of oil released by oil-glands in the skin, and helps the skin to renew itself. Accutane was Roche’s second-biggest selling drug until the patent expired in 2003, at which time generic versions could be sold.

The names of these generic versions of Isotretinoin/Acutane are Amnesteem®, Claravis™, Clarus™, Decutan, Isotane, Izotek, Oratane®, Sotret®, Isotrex®, and Isotrexin®.